id	keyword
american_scientific_journal-766	patients
american_scientific_journal-766	sofosbuvir
american_scientific_journal-766	hcv
american_scientific_journal-766	treatment
american_scientific_journal-766	hepatitis
american_scientific_journal-766	genotype
american_scientific_journal-766	ribavirin
american_scientific_journal-766	virus
american_scientific_journal-766	ifn
american_scientific_journal-766	interferon
american_scientific_journal-766	rbv
american_scientific_journal-766	inhibitors
american_scientific_journal-766	weeks
american_scientific_journal-766	combination
american_scientific_journal-766	svr
american_scientific_journal-766	peg
american_scientific_journal-766	infection
american_scientific_journal-766	drug
american_scientific_journal-766	therapy
american_scientific_journal-766	rna
american_scientific_journal-766	protease
american_scientific_journal-766	ns5a
american_scientific_journal-766	study
american_scientific_journal-766	liver